Artificial microRNAs targeting tau enable post-symptomatic functional recovery in aged tauopathy mice

Tauopathies are a group of neurodegenerative disorders, including Alzheimer’s disease, frontotemporal dementia, and progressive supranuclear palsy, characterized by the pathological accumulation of tau protein. While tau reduction has emerged as a promising disease-modifying strategy, most preclinic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Carolina Lucía Facal, Indiana Páez-Paz, A. Ezequiel Pereyra, Clara Gaguine, Ramiro Clerici-Delville, Rocío Foltran, Mariano Soiza-Reilly, María Elena Avale
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-03-01
Col·lecció:	Molecular Therapy: Nucleic Acids
Matèries:	MT: Clinical Applications gene therapy RNA therapy microRNAs artificial microRNAs tau
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2162253126000144
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!